The Study of Abatacept in Combination With Etanercept
Public ClinicalTrials.gov record NCT00162279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Intravenous Infusions of BMS-188667 (10 mg/kg) Given Monthly in Combination With Subcutaneous Injections of Etanercept (25mg)Given Twice Weekly to Subjects With Active Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.
Study identification
- NCT ID
- NCT00162279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2000 (Type not available)
- Primary completion
- Feb 2007 (Actual)
- Completion
- Feb 2007 (Actual)
- Last update posted
- Dec 6, 2010
2000 – 2007
United States locations
- U.S. sites
- 35
- U.S. states
- 23
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Huntsville | Alabama | — | — |
| Local Institution | La Jolla | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | Palo Alto | California | — | — |
| Local Institution | San Francisco | California | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Titusville | Florida | — | — |
| Local Institution | Rome | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Hagerstown | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Duluth | Minnesota | — | — |
| Local Institution | Lincoln | Nebraska | — | — |
| Local Institution | New Brunswick | New Jersey | — | — |
| Local Institution | Los Alamos | New Mexico | — | — |
| Local Institution | Albany | New York | — | — |
| Local Institution | Mineola | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Bismarck | North Dakota | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Duncansville | Pennsylvania | — | — |
| Local Institution | Norristown | Pennsylvania | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Knoxville | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Temple | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Edmonds | Washington | — | — |
| Local Institution | Tacoma | Washington | — | — |
| Local Institution | Glendale | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00162279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2010 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00162279 live on ClinicalTrials.gov.